Tagging enhances histochemical and biochemical detection of Ran Binding Protein 9 in vivo and reveals its interaction with Nucleolin

The lack of tools to reliably detect RanBP9 in vivo has significantly hampered progress in understanding the biological functions of this scaffold protein. We report here the generation of a novel mouse strain, RanBP9-TT, in which the endogenous protein is fused with a double (V5-HA) epitope tag at the C-terminus. We show that the double tag does not interfere with the essential functions of RanBP9. In contrast to RanBP9 constitutive knock-out animals, RanBP9-TT mice are viable, fertile and do not show any obvious phenotype. The V5-HA tag allows unequivocal detection of RanBP9 both by IHC and WB. Importantly, immunoprecipitation and mass spectrometry analyses reveal that the tagged protein pulls down known interactors of wild type RanBP9. Thanks to the increased detection power, we are also unveiling a previously unknown interaction with Nucleolin, a protein proposed as an ideal target for cancer treatment. In summary, we report the generation of a new mouse line in which RanBP9 expression and interactions can be reliably studied by the use of commercially available αtag antibodies. The use of this line will help to overcome some of the existing limitations in the study of RanBP9 and potentially unveil unknown functions of this protein in vivo such as those linked to Nucleolin.

[1]  Wei Yan,et al.  RAN-Binding Protein 9 is Involved in Alternative Splicing and is Critical for Male Germ Cell Development and Male Fertility , 2014, PLoS genetics.

[2]  F. Lovat,et al.  Generation of mouse lines conditionally over-expressing microRNA using the Rosa26-Lox-Stop-Lox system. , 2014, Methods in molecular biology.

[3]  Rudolf Jaenisch,et al.  One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[4]  Kay Hofmann,et al.  The yeast GID complex, a novel ubiquitin ligase (E3) involved in the regulation of carbohydrate metabolism. , 2008, Molecular biology of the cell.

[5]  V. Coppola,et al.  Scorpins in the DNA Damage Response , 2018, International journal of molecular sciences.

[6]  L. Tessarollo,et al.  RanBPM, a scaffolding protein for gametogenesis. , 2013, Current topics in developmental biology.

[7]  T. Ludwig,et al.  Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells , 2016, Oncotarget.

[8]  Thorsten Pfirrmann,et al.  The Gid-complex: an emerging player in the ubiquitin ligase league , 2019, Biological chemistry.

[9]  J. Carroll,et al.  Rapid immunoprecipitation mass spectrometry of endogenous proteins (RIME) for analysis of chromatin complexes , 2016, Nature Protocols.

[10]  Conrad C. Huang,et al.  BayGenomics: a resource of insertional mutations in mouse embryonic stem cells , 2003, Nucleic Acids Res..

[11]  R. Jaenisch,et al.  One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[12]  C. Schild-Poulter,et al.  RanBPM Has Proapoptotic Activities That Regulate Cell Death Pathways in Response to DNA Damage , 2009, Molecular Cancer Research.

[13]  E. Messing,et al.  A novel MET-interacting protein shares high sequence similarity with RanBPM, but fails to stimulate MET-induced Ras/Erk signaling. , 2004, Biochemical and biophysical research communications.

[14]  G. Lajoie,et al.  The mammalian CTLH complex is an E3 ubiquitin ligase that targets its subunit muskelin for degradation , 2019, Scientific Reports.

[15]  Michael G Weller,et al.  Quality Issues of Research Antibodies , 2016, Analytical chemistry insights.

[16]  Michael C. Ostrowski,et al.  Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo , 2015, Genes & development.

[17]  J. Reuther,et al.  Exploring the Topology of the Gid Complex, the E3 Ubiquitin Ligase Involved in Catabolite-induced Degradation of Gluconeogenic Enzymes* , 2012, The Journal of Biological Chemistry.

[18]  P. Bouvet,et al.  Multifaceted Nucleolin Protein and Its Molecular Partners in Oncogenesis. , 2018, Advances in protein chemistry and structural biology.

[19]  J. Herz,et al.  An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo. , 2014, The Journal of clinical investigation.

[20]  Matthias Mann,et al.  The Q Exactive HF, a Benchtop Mass Spectrometer with a Pre-filter, High-performance Quadrupole and an Ultra-high-field Orbitrap Analyzer* , 2014, Molecular & Cellular Proteomics.

[21]  JLA Voskuil,et al.  Commercial antibodies and their validation , 2014, F1000Research.

[22]  V. Coppola,et al.  RanBPM is essential for mouse spermatogenesis and oogenesis , 2011, Development.

[23]  D. Kang,et al.  RanBP9 Plays a Critical Role in Neonatal Brain Development in Mice , 2013, PloS one.

[24]  M. Takagi,et al.  Regulation of p53 Translation and Induction after DNA Damage by Ribosomal Protein L26 and Nucleolin , 2005, Cell.

[25]  Giel Vandemoortele,et al.  Pick a Tag and Explore the Functions of Your Pet Protein. , 2019, Trends in biotechnology.

[26]  C. Croce,et al.  RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patients , 2018, Oncogene.

[27]  M. Peter,et al.  The multi-subunit GID/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation , 2018, eLife.

[28]  T. Gibson,et al.  Elution Profile Analysis of SDS-induced Subcomplexes by Quantitative Mass Spectrometry* , 2014, Molecular & Cellular Proteomics.

[29]  C. Schild-Poulter,et al.  Cell signalling pathway regulation by RanBPM: molecular insights and disease implications , 2017, Open Biology.

[30]  C. Schild-Poulter,et al.  RanBPM Is an Inhibitor of ERK Signaling , 2012, PloS one.

[31]  D. Chan,et al.  Analysis of the Human Endogenous Coregulator Complexome , 2011, Cell.

[32]  Michael A. Freitas,et al.  In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation , 2013, The Journal of experimental medicine.